The recent shortage of GLP-1 drugs has come to an end, but for some patients, this is not entirely good news. The shortage of Mounjaro and Zepbound has led to many patients seeking compounded versions of these medications. Now that the original drugs are back in stock, these patients are facing a new challenge – finding a pharmacy that can fill their compounded prescriptions.
According to Scott Brunner, CEO of the Alliance for Pharmacy Compounding, many patients are now left in a difficult situation. They have prescriptions for compounded drugs that can no longer be filled, and they are struggling to find pharmacies that can provide them with the necessary medications.
Brunner explains that the issue lies in the fact that compounded drugs are not FDA-approved, and therefore, pharmacies are not required to stock them. This means that patients may have to call around to multiple pharmacies in order to find one that can fill their prescription.
In addition, the cost of compounded drugs can vary significantly from pharmacy to pharmacy. This can be a major issue for patients who are already struggling to afford their medications.
For patients who are taking compounded GLP-1 medications, it is important to speak with their doctor about their options. They may be able to switch to a different type of medication or find a pharmacy that can fill their compounded prescription.
Be First to Comment